 |
|
|
|
|
|
|
|
|
|
|
|
1 to 21 of 21 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Davies P. on PAPER: Akoury E. et al., 2013, The assumption behind all the work with methylene blue is that inhibition of tau aggregation is... 21 Feb 2013.
|
|
|
 |
|
|
Davies P. on PAPER: Barten DM. et al., 2012, One curious point about this drug, epothilone D, is that the drug is so effective at cutting... 26 May 2012.
|
|
|
|
|
|
Davies P. on NEWS: NIH Director Announces $100M Prevention Trial of Genentech Antibody, This is interesting from several points of view. I wonder if these studies in AD mutation... 18 May 2012.
|
|
|
|
|
|
Davies P. on PAPER: Zhang Y. et al., 2010, The results described are surprising, and do not readily fit with the work
from Mucke's group on... 24 Oct 2010.
|
|
|
|
|
|
Davies P. on NEWS: A Tribute to Robert Katzman, I was lucky enough to work with the two giants of the Alzheimer disease field in the early days... 26 Sep 2008.
|
|
|
|
|
|
Davies P. on LIVE DISCUSSION: Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?, It is clear from the responses to our original posting that many people recognize that the... 19 May 2006.
|
|
|
|
|
|
Davies P. on LIVE DISCUSSION: Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?, Bart De Strooper and colleagues have just published a paper on the effects of presenilin (PS)... 25 Mar 2006.
|
|
|
|
|
|
Davies P. on NEWS: We Are What We Consume? Foods, Drugs Affect Amyloid, AD, Regarding the impact of certain foods, beverages, and drugs on the development of AD, I think it... 25 Oct 2005.
|
|
|
|
|
|
Davies P. on NEWS: Can Travel, Will Deposit: Aβ via the Perforant Pathway?, Tangles Come before Plaques on the Perforant Pathway
The one system where transport of APP... 18 Nov 2002.
|
|
|
|
|
|
Davies P. on NEWS: Spinal Taps for Tau Tests, The ability to accurately identify patients with MCI who will progress to AD would be a great... 18 Nov 2002.
|
|
|
|
|
|
Davies P. on PAPER: von Bergen M. et al., 2001, "This paper continues the Mandelkow's fine work trying to unravel the mechanism of PHF formation... 29 Jun 2002.
|
|
|
|
|
|
Davies P. on PAPER: Tanzi RE. et al., 1996, A good, authoritative, up-to-date- review. No date saved.
|
|
|
|
|
|
Davies P. on PAPER: Xu PT. et al., 1996, These new animals may be useful tools in AD research. No date saved.
|
|
|
|
|
|
Davies P. on PAPER: Yang Y. et al., 2001, This paper from Karl Herrup and colleagues is really fantastic. I saw some of the data in... No date saved.
|
|
|
|
|
|
Davies P. on PAPER: Enserink M. et al., 1998, Alzheimer was right all the time! No date saved.
|
|
|
|
|
|
Davies P. on PAPER: Su JH. et al., 1997, This paper appears to provide quite good evidence for activation of some kind of apoptotic... No date saved.
|
|
|
|
|
|
Davies P. on PAPER: Zheng-Fischhöfer Q. et al., 1998, We need the detailed phosphorylation mechanism of tau to understand cell death. This is but one... No date saved.
|
|
|
|
|
|
Davies P. on PAPER: Fagan AM. et al., 1996, A very well done apoE paper No date saved.
|
|
|
|
|
|
Davies P. on PAPER: Hashimoto Y. et al., 2001, There are some unusual things in this paper. They have a mRNA that is almost 1600 bases long,... No date saved.
|
|
|
|
|
|
Davies P. on NEWS: Transgenic Mice Accumulate Human Tau in Degenerating Hippocampal Neurons, The Takashima mice are remarkable, as they appear to express high levels of
the mutant tau... 7 Jan 2002.
|
|
|
|
|
|
Davies P. on NEWS: New Study Correlates Aβ Levels to Degree of Dementia, The study shows that both the 40 and 42 amino acid amyloid peptides were elevated early in... 5 Apr 2000.
|
|
|
|
|
|
|
1 to 21 of 21 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
